Shingo Tetsuro
Department of Neurological Surgery, Okayama University Graduate School of Medicine & Dentistry.
Rinsho Shinkeigaku. 2004 Nov;44(11):951-3.
An approach for symptomatic Parkinson's disease (PD) therapy is fetal dopamine neuron transplantation. This approach remains the technical and ethical difficulties in obtaining sufficient and appropriate donor fetal brain tissue. In developments of stem cell biology, neural stem cells exist in the adult brain as well as embryo and have the capacity to regenerate and to give rise to the three cell lineages in the nervous system. Embryonic stem cells (ES cells) and multipotent adult progenitor cells (MAPCs) are pluripotent cells, which give rise to all cells in the organism. Current findings suggest that stem cells but not fetal brain tissues may be suitable for cell replacement therapies in the treatment of neurodegenerative disorders. We will briefly review the current state of cell therapy, and will critically discuss the potential of stem cells for the treatment of PD.
一种用于治疗帕金森病(PD)症状的方法是胎儿多巴胺神经元移植。这种方法在获取足够且合适的供体胎儿脑组织方面仍然存在技术和伦理难题。在干细胞生物学的发展中,神经干细胞存在于成体大脑以及胚胎中,并且具有再生能力以及分化为神经系统中三种细胞谱系的能力。胚胎干细胞(ES细胞)和多能成体祖细胞(MAPC)是多能细胞,它们能够分化为生物体中的所有细胞。目前的研究结果表明,干细胞而非胎儿脑组织可能适用于神经退行性疾病治疗中的细胞替代疗法。我们将简要回顾细胞治疗的现状,并批判性地讨论干细胞治疗帕金森病的潜力。